InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,223.99
(
0.03%
)
US TECH 100
17,724.40
(
0.24%
)
Dow Jones
39,531.14
(
0.05%
)
Brent Oil
83.26
(
1.06%
)
Bitcoin
62,801.17
(
2.20%
)
Post# of 1434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rikic

Send PM Follow Ignore
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

rikic

Re: None

Tuesday, 09/22/2015 7:37:03 AM

Tuesday, September 22, 2015 7:37:03 AM

Post# of 1434
Aradigm Corporation Completes Enrollment in Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (ORBIT-4)

http://investor.aradigm.com/releasedetail.cfm?ReleaseID=932534
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up